| Literature DB >> 35351517 |
Andrea Zancla1, Pamela Mozetic2, Monica Orsini3, Giancarlo Forte4, Alberto Rainer5.
Abstract
Traction force microscopy (TFM) has emerged as a versatile technique for the measurement of single-cell-generated forces. TFM has gained wide use among mechanobiology laboratories, and several variants of the original methodology have been proposed. However, issues related to the experimental setup and, most importantly, data analysis of cell traction datasets may restrain the adoption of TFM by a wider community. In this review, we summarize the state of the art in TFM-related research, with a focus on the analytical methods underlying data analysis. We aim to provide the reader with a friendly compendium underlying the potential of TFM and emphasizing the methodological framework required for a thorough understanding of experimental data. We also compile a list of data analytics tools freely available to the scientific community for the furtherance of knowledge on this powerful technique.Entities:
Keywords: biophysics; cell adhesion; cytoskeleton; focal adhesion; mechanosignaling; mechanotransduction; traction force microscopy
Mesh:
Year: 2022 PMID: 35351517 PMCID: PMC9092999 DOI: 10.1016/j.jbc.2022.101867
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.486
Figure 1Simplified schematic representation of the focal adhesions. Following integrin contact with the extracellular matrix (ECM), docking proteins are recruited that transfer the external stimuli toward the cytoskeleton, where traction forces are generated by the interaction between filamentous actin (F-actin) fibers and the motor protein myosin.
Figure 2Advanced variants of TFM technique. Image thumbnails have been adapted with permission from the corresponding references. A, TFM substrate micropatterning (40). B, 2.5D and 3D TFM (44). C, elastic resonator interference stress microscopy (ERISM) (52). D, reference-free TFM (54). E, super-resolved TFM (55, 58). QD, quantum dot; SIM, structured illumination microscopy; STED, STimulated Emission Depletion; TFM, traction force microscopy.
Figure 3Effect of the chosen regularization parameter on the estimation of the traction force magnitude. A, sample cell, expressing a fluorescent variant of the FA-associated protein paxillin (in green) and adherent to a 15-kPa (shear modulus) polyacrylamide gel laden with fluorescent nanoparticles (in red). Scale bar: 50 μm. B, reference image of the same ROI after cell detachment by trypsinization. Datasets were processed using PIV/FTTC plugins for ImageJ (see BOX 2 for details on software tools), and the resulting traction maps were post-processed in MATLAB (MathWorks, R2019b) for visualization. C, displacement vector field calculated by PIV algorithm. D-H, traction maps obtained from the displacement field in (C) using FTTC plugin with different values for the regularization parameter (in the range 1E-9 – 1E-11). The same colormap value ranges were used for all traction maps, emphasizing the impact of the chosen regularization parameter on the resulting solution. FA, focal adhesion; FTTC, Fourier transform traction cytometry; PIV, particle image velocimetry; ROI, range of interest.
Figure 4Output of TFM analysis performed by PIV/FTTC plugins for ImageJ. Source dataset is as in Figure 3. A, vector plot of the displacement field (in pixels). B, vector plot of the cell traction field (in Pa). FTTC, Fourier transform traction cytometry; PIV, particle image velocimetry; TFM, traction force microscopy.
Figure 5Output of Danuser Lab TFM package in MATLAB. Source dataset is as in Figure 3. A, displacement map (in pixels). B, traction intensity map (in Pa). TFM, traction force microscopy
A list of relevant applications of traction force microscopy, with a detail of the biological inquiry and the cell models used
| Biological inquiry | Cell type | Ref |
|---|---|---|
| Role of substrate stiffness | Human mesenchymal stromal cells | ( |
| Neonatal rat ventricular myocytes | ( | |
| Human embryonic stem cells | ( | |
| Human cardiac fibroblasts | ( | |
| Cardiomyocytes | ( | |
| Epithelial bladder cancer cells (T24) | ( | |
| Breast cancer cells (MCF10A/MCF10AT, MDA-MB-231) | ( | |
| Lung cancer cells (A-549, BEAS2B) | ( | |
| Prostate cancer cells (PC3, PrEC) | ( | |
| Cell contraction | Human iPSC-derived cardiomyocytes | ( |
| Neonatal rat ventricular myocytes | ( | |
| Valve interstitial cells | ( | |
| Breast cancer cells (MCF10A/MCF10AT) | ( | |
| Epithelial cells | ( | |
| Cell migration | Murine fibroblast line (NIH/3T3) | ( |
| Goldfish fin fibroblasts (CCL-71) | ( | |
| MDCK epithelial cells | ( | |
| ( | ||
| Breast cancer cells (MCF10a/MCF10AT, MDA-MB-231) | ( | |
| Lung cancer cells (A-549, BEAS2B) | ( | |
| Prostate cancer cells (PC3, PrEC) | ( | |
| Cell invasiveness | Lung cancer cells (A-125, A-549) | ( |
| Breast cancer cells (MDA-MB-123, MCF7) | ( | |
| Squamous carcinoma cells (A-431) | ( | |
| Epithelial bladder cancer cells (T24, RT112) | ( | |
| Focal adhesion organization | Human foreskin fibroblasts | ( |
| Goldfish fin fibroblasts (CCL-71) | ( | |
| HaCaT keratinocytes | ( | |
| Mouse embryonic fibroblasts | ( | |
| Breast cancer cells (CAL51) | ( | |
| Murine fibroblast line (NIH/3T3) | ( | |
| Epithelial ovarian cancer cells (OVCAR5) | ( | |
| Breast cancer cells (MDA-MB-231) | ( | |
| Prostate cancer cells (PC3) | ( | |
| Colorectal adenocarcinoma cells (SW480) | ( | |
| Mouse embryonic fibroblasts | ( | |
| Breast cancer cells (CAL51) | ( |